Scientists at the UW Carbone Cancer Center are in human trial phase for a vaccine to treat aggressive forms of prostate cancer. The first patient in the trial received the medicine this week. Each year about 240,000 men are diagnosed with prostate cancer in the US, and the disease re-occurs in about one-third of them.
Office of Strategic Communication